Stock Price
10.07
Daily Change
-0.34 -3.27%
Monthly
-16.71%
Yearly
-39.70%
Q2 Forecast
9.87

Dentsply International reported $5.23B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
3M USD 35.44B 2.3B Mar/2026
Agilent USD 12.81B 86M Dec/2025
Align Technology USD 6.31B 80.48M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cooper Companies USD 12.42B 29.4M Dec/2025
CVS Health USD 252.97B 564M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
Intuitive Surgical USD 20.11B 347.7M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
McKesson USD 82.32B 1.87B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Owens Minor USD 2.42B 35.78M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025
Stryker USD 46.29B 1.55B Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Veradigm USD 1.5B 185.94M Dec/2022
Waters USD 24.53B 19.45B Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026
Zoetis USD 15.15B 313M Mar/2026